On June 21, Virbac announced that it had finalized the acquisition of minority shares in Globion, thereby increasing its stake to 100%.

This transaction follows the acquisition of a 74% majority stake on November 1, 2023.

Founded in 2005 as a joint venture between Suguna Group (an Indian poultry conglomerate) and Lohmann Animal Health (a German poultry vaccine specialist), Globion has developed solid know-how and expertise in the development, manufacture and marketing of live and inactivated vaccines targeting a wide range of avian pathogens.

Globion is based in Hyderabad, where its industrial and R&D facilities employ around 120 full-time staff, and generated sales of around 12 million euros in 2023.

Copyright (c) 2024 CercleFinance.com. All rights reserved.